{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:21:49Z","timestamp":1794921709850,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.rmed.2025.108171","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T12:11:16Z","timestamp":1747829476000},"page":"108171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Impact of availability of a highly effective cystic fibrosis treatment (elexacaftor\/tezacaftor\/ivacaftor) on lung transplant waitlist and lung transplantation trends in the US"],"prefix":"10.1016","volume":"245","author":[{"given":"Christian","family":"Merlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Morlando","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3556-8092","authenticated-orcid":false,"given":"Zailong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1408-851X","authenticated-orcid":false,"given":"Grace R.","family":"Lyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3793-5745","authenticated-orcid":false,"given":"David P.","family":"Schladt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"McGarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2025.108171_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2025.108171_bib2","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2025.108171_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"Lung transplant referral for individuals with cystic fibrosis: cystic Fibrosis Foundation consensus guidelines","volume":"18","author":"Ramos","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2025.108171_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0035-1547347","article-title":"Lung transplantation for cystic fibrosis: results, indications, complications, and controversies","volume":"36","author":"Lynch","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108171_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039809","article-title":"A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease","volume":"7","author":"Sloane","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2025.108171_bib7","first-page":"567","article-title":"Pharmaceutical approval update","volume":"40","author":"Gohil","year":"2015","journal-title":"P T"},{"key":"10.1016\/j.rmed.2025.108171_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1164\/rccm.201704-0717OC","article-title":"Tezacaftor\/Ivacaftor in Subjects with Cystic Fibrosis and F508del\/F508del-CFTR or F508del\/G551D-CFTR","volume":"197","author":"Donaldson","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108171_bib9","series-title":"Trikafta\u00ae(elexacaftor\/tezacaftor\/ivacaftor)[package Insert]","author":"Incorporated","year":"2019"},{"key":"10.1016\/j.rmed.2025.108171_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jcf.2023.03.002","article-title":"Real-world safety and effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: interim results of a long-term registry-based study","volume":"22","author":"Bower","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2025.108171_bib11","series-title":"Real-world Outcomes in People with Cystic Fibrosis (pwCF) Treated with Elexacaftor\/Tezacaftor\/Ivacaftor (ELX\/TEZ\/IVA) with up to Three Years of Follow-Up","author":"Bower","year":"2024"},{"key":"10.1016\/j.rmed.2025.108171_bib12","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01402-2022","article-title":"Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor-tezacaftor-ivacaftor, Germany, 2012-2021","volume":"61","author":"Ringshausen","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108171_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1164\/rccm.201906-1227OC","article-title":"Real-life safety and effectiveness of lumacaftor-ivacaftor in patients with cystic fibrosis","volume":"201","author":"Burgel","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108171_bib14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jcf.2021.05.009","article-title":"Short-term effect of elexacaftor-tezacaftor-ivacaftor on lung function and transplant planning in cystic fibrosis patients with advanced lung disease","volume":"20","author":"Bermingham","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2025.108171_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s41030-023-00241-z","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on healthcare resource utilization and associated costs among people with cystic fibrosis in the us: a retrospective claims analysis","volume":"9","author":"Schechter","year":"2023","journal-title":"Pulm Ther"},{"key":"10.1016\/j.rmed.2025.108171_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s41030-021-00154-9","article-title":"Long-Term impact of ivacaftor on healthcare resource utilization among people with cystic fibrosis in the United States","volume":"7","author":"Thorat","year":"2021","journal-title":"Pulm Ther"},{"key":"10.1016\/j.rmed.2025.108171_bib17","unstructured":"Data That Drives Development. The SRTR Database. [cited 2024 April 2]. Available from: https:\/\/www.srtr.org\/about-the-data\/the-srtr-database."},{"key":"10.1016\/j.rmed.2025.108171_bib18","unstructured":"Organ Procurement & Transplantation Network (OPTN): Data collection. [cited 2024 April 8]. Available from: https:\/\/optn.transplant.hrsa.gov\/data\/about-data\/data-collection\/."},{"key":"10.1016\/j.rmed.2025.108171_bib19","unstructured":"Cystic Fibrosis Foundation. Being Referred as a Candidate for Lung Transplant. [cited 2024 April 8]. Available from:. https:\/\/www.cff.org\/managing-cf\/being-referred-candidate-lung-transplant."},{"key":"10.1016\/j.rmed.2025.108171_bib21","doi-asserted-by":"crossref","first-page":"S422","DOI":"10.1016\/j.ajt.2025.01.025","article-title":"OPTN\/SRTR 2023 annual data report: lung","volume":"25","author":"Valapour","year":"2025","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.rmed.2025.108171_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/rccm.202011-4153OC","article-title":"Rapid improvement after starting elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis and advanced pulmonary disease","volume":"204","author":"Burgel","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108171_bib23","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/ppul.25285","article-title":"Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype","volume":"56","author":"McGarry","year":"2021","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.rmed.2025.108171_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcf.2024.07.015","article-title":"Characteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor\/tezacaftor\/ivacaftor","volume":"24","author":"Sanders","year":"2025","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2025.108171_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jcf.2025.01.006","article-title":"Racial disparities in lung transplantation for cystic fibrosis in the era of highly effective modulator therapy","volume":"24","author":"Ruck","year":"2025","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2025.108171_bib26","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1111\/ajt.16199","article-title":"Organ donation during the COVID-19 pandemic","volume":"20","author":"Ahmed","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.rmed.2025.108171_bib27","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1016\/S2468-2667(21)00200-0","article-title":"COVID-19 pandemic and worldwide organ transplantation: a population-based study","volume":"6","author":"Aubert","year":"2021","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.rmed.2025.108171_bib28","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1097\/TP.0000000000003391","article-title":"Early impact of COVID-19 on solid organ transplantation in the United States","volume":"104","author":"Cholankeril","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.rmed.2025.108171_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106120","article-title":"Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic","volume":"191","author":"Berghaus","year":"2022","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108171_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13052-021-00970-4","article-title":"COVID-19 lockdown beneficial effects on lung function in a cohort of cystic fibrosis patients","volume":"47","author":"Servidio","year":"2021","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.rmed.2025.108171_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/TP.0000000000003522","article-title":"Trends in lung transplantation practices across the United States during the COVID-19 pandemic","volume":"105","author":"Chan","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.rmed.2025.108171_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14596","article-title":"Impact of COVID-19 pandemic on the size of US transplant waiting lists","volume":"36","author":"Miller","year":"2022","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.rmed.2025.108171_bib33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.202109-2121LE","article-title":"Major decrease in lung transplantation for patients with cystic fibrosis in France","volume":"205","author":"Martin","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125002331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125002331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:32:44Z","timestamp":1764919964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125002331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":31,"alternative-id":["S0954611125002331"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108171","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of availability of a highly effective cystic fibrosis treatment (elexacaftor\/tezacaftor\/ivacaftor) on lung transplant waitlist and lung transplantation trends in the US","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108171"}}